Would Big Pharma Pay for the Wall?

United States News News

Would Big Pharma Pay for the Wall?
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

The government shutdown over funding for the border wall may start to put a dent in the prodigious cash flows of big drug and biotech firms

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A Big, Fatty Opportunity for Big PharmaA Big, Fatty Opportunity for Big PharmaThe next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first.
Read more »

Samsung Faces Resistance From Big Pharma in the U.S.Samsung Faces Resistance From Big Pharma in the U.S.Samsung’s foray into the U.S. biologic-drug market is proving tougher than expected, as the South Korean company faces strong resistance from established pharmaceutical companies while doctors and patients are reluctant to switch to biosimilars.
Read more »

Posh And Purposeful: The Hottest Luxury Cars For 2019 Are Pickup TrucksPosh And Purposeful: The Hottest Luxury Cars For 2019 Are Pickup TrucksBig pickups mean big profits for automakers, especially the current crop of luxury-equipped haulers that start in the $50,000 range and can extend well beyond $60,000 and even $70,000 when fully loaded.
Read more »

The Exchange: Big Weed's big yearThe Exchange: Big Weed's big yearListen: Bruce Linton runs the world's biggest cannabis producer, Canopy Growth. He visited Breakingviews to discuss what's coming down the pipe in 2019, why a $100 bln weed company is still some way off, and why he doesn't actually partake - yet.
Read more »

From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019From Amgen to Gilead, drugmakers are sitting on billions of cash — and top pharma executives are hinting about big M&A to come in 2019Billion-dollar deals from drug giants Eli Lilly & Co. and Bristol-Myers Squibb could set the tone for a year full of healthcare acquisitions.
Read more »

Sen. Bernie Sanders says 'we will end' Big Pharma 'greed' in legislative push to cut drug pricesSen. Bernie Sanders says 'we will end' Big Pharma 'greed' in legislative push to cut drug pricesThe bills, led by Sanders and Reps. Elijah Cummings and Ro Khanna, would permit Health and Human Services Secretary Alex Azar to negotiate lower prices for drugs under Medicare Part D, the federal program for prescription drug benefits.
Read more »



Render Time: 2025-02-26 22:07:19